Consultant for the Pharmacotherapy of Schizophrenia
- 1 May 1999
- journal article
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 29 (5) , 252-267
- https://doi.org/10.3928/0048-5713-19990501-08
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Which atypical antipsychotic?The British Journal of Psychiatry, 1998
- Extrapyramidal Signs and Clinical Symptoms in First-Episode SchizophreniaJournal of Clinical Psychopharmacology, 1997
- Clozapine-induced electroencephalogram changes as a function of clozapine serum levelsBiological Psychiatry, 1997
- Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical FindingsSchizophrenia Bulletin, 1997
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- Pimozide Is Effective in Delirium Secondary to Hypercalcemia When Other Neuroleptics FailPsychosomatics, 1993
- Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patientsBiological Psychiatry, 1993
- Droperidol versus haloperidol for chemical restraint of agitated and combative patientsAnnals of Emergency Medicine, 1992
- Mesoridazine in Neuroleptic-Resistant PsychosesJournal of Clinical Psychopharmacology, 1991
- Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patientsSchizophrenia Research, 1991